Neoadjuvant pembrolizumab plus decitabine followed by standard neoadjuvant chemotherapy for locally advanced HER2-breast cancer (NCT02957968)

被引：1
|
作者：
Bear, Harry
Deng, Xiaoyan
Bandyopadhyay, Dipankar
Idowu, Michael
Kmieciak, Maciej
Williams, Monique
Archer, Giovanni
Gwaltney, Lindsey
Dillon, Patrick
Flora, Daniel
Stover, Daniel
Poklepovic, Andrew
Hackney, Mary
Ross, Masey
Vachhani, Hetal
Louie, Raphael
McGuire, Kandace
Grover, Amelia
Rahman, Tasnim
Hendrix, Amber
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-18-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-18-04
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal cancer
    Cheng, X.
    Chen, Y.
    Wu, X.
    Hao, D.
    Zhang, Y.
    Li, X.
    ANNALS OF ONCOLOGY, 2016, 27
  • [22] Neoadjuvant chemotherapy plus immunotherapy for locally advanced esophageal cancer
    Zhou, Jingyue
    Zhang, Gan
    Xie, Minghua
    Ren, Zixue
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (09): : 4840 - 4848
  • [23] The Efficacy of Neoadjuvant Chemotherapy for HER-2-Positive Locally Advanced Breast Cancer and Survival Analysis
    Zhang, Wei
    Tian, Huan
    Yang, Shi-hong
    ANALYTICAL CELLULAR PATHOLOGY, 2017, 2017
  • [24] The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer
    Hirano, A
    Shimizu, T
    Imamura, H
    Watanabe, O
    Kinoshita, J
    Okabe, T
    Kimura, K
    Kamimura, M
    Domoto, K
    Aiba, M
    Ogawa, K
    ANTICANCER RESEARCH, 2006, 26 (1B) : 581 - 584
  • [25] High antitumoral activity of neoadjuvant chemotherapy (NCT) with weekly paclitaxel plus capecitabine and trastuzumab in patients with locally advanced HER2+breast cancer (HER2+LABC): Preliminary results
    Augereau, P.
    Raro, P.
    Verriele, V.
    Delva, R.
    Abadie-Lacourtoisie, S.
    Ceban, T.
    Paillocher, N.
    Valo, I.
    Maillart, P.
    Soulie, P.
    CANCER RESEARCH, 2012, 72
  • [26] Neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer
    Venkataramana, Vinay Babu
    Anand, Vivek
    Bajpai, Ranjeet
    Paul, Simon
    Hinduja, Ritika
    Bhadane, Manish
    Deshpande, Sudesh
    Naidu, Suresh
    Kapadia, Asha
    Almel, Sachin
    Lala, Murad
    Venkatesan, Kannan
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1064 - S1065
  • [27] Analysis of response to neoadjuvant chemotherapy (NCT) with doxorubicin plus cyclophosphamide followed by paclitaxel (AC- T) in triple negative locally advanced breast cancer (LABC) in Brazil
    Nunes, J. S.
    Tsunoda, A. T.
    Viana, L. S.
    Souza, F. H.
    Castro, N.
    Hohmann, J.
    Serrano, S. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Standard Neoadjuvant Treatment in Early/Locally Advanced Breast Cancer
    Pernaut, Cristina
    Lopez, Flora
    Ciruelos, Eva
    BREAST CARE, 2018, 13 (04) : 244 - 249
  • [29] Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude
    Debled, Marc
    MacGrogan, Gaetan
    Breton-Callu, Christelle
    Ferron, Stephane
    Hurtevent, Gabrielle
    Fournier, Marion
    Bourdarias, Lionel
    Bonnefoi, Herve
    Mauriac, Louis
    de Lara, Christine Tunon
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (06) : 697 - 704
  • [30] Neoadjuvant chemotherapy for Chinese women with locally advanced breast cancer
    Chow, LWC
    Day, WD
    Ng, KCK
    AMERICAN SURGEON, 2001, 67 (05) : 412 - 416
12345